Toro Carlos, Soriano Vincent, Tuset Concepción, Aguilera Antonio, Caballero Estrella, de Lejarazu Raul Ortiz, Rodés Berta
Service of Infectious Diseases, Hospital Carlos III, Instituto de Salud Carlos III, Madrid, Spain.
HIV Clin Trials. 2002 Sep-Oct;3(5):397-402. doi: 10.1310/c0xr-f0q4-vr3x-yrbn.
HIV-2, human T-cell lymphotropic virus (HTLV)-I, and HTLV-II infections are currently circulating in Spain with no evidence of an increase in the number of reported cases over time. Up to June 2002, a total of 106, 53, and 460 cases of HIV-2, HTLV-I, and HTLV-II infection, respectively, have been identified in Spain. Most HIV-2-infected and HTLV-I-infected individuals are immigrants who come from endemic areas or are Spaniards with a past history of travel to or sexual contacts with persons originating in those areas. In contrast, HTLV-II infection is mainly limited to native intravenous drug users who are frequently coinfected with HIV-1.
人类免疫缺陷病毒2型(HIV-2)、人类嗜T淋巴细胞病毒1型(HTLV-I)和人类嗜T淋巴细胞病毒2型(HTLV-II)感染目前在西班牙传播,没有证据表明报告病例数随时间增加。截至2002年6月,西班牙分别共确诊了106例HIV-2感染、53例HTLV-I感染和460例HTLV-II感染。大多数HIV-2感染者和HTLV-I感染者是来自流行地区的移民,或是有前往这些地区旅行史或与这些地区人员有性接触史的西班牙人。相比之下,HTLV-II感染主要局限于经常合并感染HIV-1的本地静脉注射吸毒者。